Understanding the interactions of diruthenium anticancer agents with amino acids

Author(s)
Alexey A. Nazarov, Maria Grazia Mendoza Parra Ferri, Muhammad Hanif, Bernhard K. Keppler, Paul J. Dyson, Christian G. Hartinger
Abstract

Abstract: The dinuclear anticancer agents 1,n-bis{chlorido[3-(oxo-κO)-2-methyl-4-(1H)-pyridinonato-κO4](η

6-p-cymene)-ruthenium(II)}alkane (PyRu

2

n) exhibit high antiproliferative activity in human cancer cell. Reactivity studies with DNA and protein revealed uncommon protein–DNA and DNA–DNA crosslinking ability. We report here studies on the reactions of the diruthenium organometallics PyRu

2

6 and PyRu

2

8 in comparison with a mononuclear analogue PyRu

3 with amino acids using mass spectrometry and NMR spectroscopy. The compounds behave very similarly, independent of the spacer length between the metal center and of the nuclearity of the complexes. Incubation with l-cysteine (Cys) results in fast release of the pyridone ligand, with the Ru complexes able to form Cys adducts. In contrast, l-methionine forms, initially, adducts with the metal centers, but over time, the adducts decompose. Similar behavior was observed for the reaction with l-histidine with [Ru(η

6-p-cymene)(l-histidine)] species detected. Graphical abstract: [Figure not available: see fulltext.].

Organisation(s)
Department of Inorganic Chemistry
External organisation(s)
Anuchin Research Institute and Museum of Anthropology, University of Auckland, École polytechnique fédérale de Lausanne
Journal
Journal of Biological Inorganic Chemistry
Volume
23
Pages
1159-1164
No. of pages
6
ISSN
0949-8257
DOI
https://doi.org/10.1007/s00775-018-1597-x
Publication date
10-2018
Peer reviewed
Yes
Austrian Fields of Science 2012
104003 Inorganic chemistry, 301904 Cancer research
Keywords
ASJC Scopus subject areas
Biochemistry, Inorganic Chemistry
Sustainable Development Goals
SDG 3 - Good Health and Well-being
Portal url
https://ucrisportal.univie.ac.at/en/publications/3670f071-7b08-4a76-8db9-660128410ece